KOZARICH JOHN W sold 1.1% of their position (467.00 shares) of LIGAND PHARMACEUTICALS INC on the open market
Open‑market sale worth $91.5K — a minor trim. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 5 sales
Filed: 2/4/2026ACC: 0002001011-26-000007
-467.00
Net shares
Net seller
$91.5K
Total sold
5
Open market trades
0B · 5S
5
Total transactions
467.00 disposed
Non-Derivative Transactions5
Common Stock
Direct
Shares
−39.00
Price / share
$191.00
Trade value
$7.45K
% of position
0.1%
2/2/2026
43.65K→43.62K
Common Stock
Direct
Shares
−1.00
Price / share
$192.18
Trade value
$192.18
% of position
0.0%
2/2/2026
43.62K→43.61K
Common Stock
Direct
Shares
−23.00
Price / share
$195.60
Trade value
$4.50K
% of position
0.1%
2/2/2026
43.61K→43.59K
Common Stock
Direct
Shares
−381.00
Price / share
$196.36
Trade value
$74.81K
% of position
0.9%
2/2/2026
43.59K→43.21K
Common Stock
Direct
Shares
−23.00
Price / share
$197.19
Trade value
$4.54K
% of position
0.1%
2/2/2026
43.21K→43.19K
Total
Net shares
−467.00
Net value
-$91.49K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/2/2026 | S · Sale | −39.00 | $191.00 | $7.45K | 0.1% | 43.65K | 43.62K |
| Common Stock Direct | 2/2/2026 | S · Sale | −1.00 | $192.18 | $192.18 | 0.0% | 43.62K | 43.61K |
| Common Stock Direct | 2/2/2026 | S · Sale | −23.00 | $195.60 | $4.50K | 0.1% | 43.61K | 43.59K |
| Common Stock Direct | 2/2/2026 | S · Sale | −381.00 | $196.36 | $74.81K | 0.9% | 43.59K | 43.21K |
| Common Stock Direct | 2/2/2026 | S · Sale | −23.00 | $197.19 | $4.54K | 0.1% | 43.21K | 43.19K |
| Total | −467.00 | -$91.49K | ||||||
Derivative Transactions0
No derivative transactions reported